image
Healthcare - Biotechnology - NASDAQ - US
$ 2.42
-3.53 %
$ 6.17 M
Market Cap
-0.48
P/E
BALANCE SHEET
2.67 M ASSETS
-25.25%
754 K LIABILITIES
74.34%
1.92 M EQUITY
-38.96%
BALANCE SHEET DECOMPOSITION
Balance Sheet Lipella Pharmaceuticals Inc.
image
Current Assets 2.62 M
Cash & Short-Term Investments 2.18 M
Receivables 84.7 K
Other Current Assets 348 K
Non-Current Assets 56.6 K
Long-Term Investments 0
PP&E 56.6 K
Other Non-Current Assets 0
81.71 %3.17 %13.00 %Total Assets$2.7m
Current Liabilities 754 K
Accounts Payable 388 K
Short-Term Debt 47.6 K
Other Current Liabilities 319 K
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0
51.46 %6.31 %42.23 %Total Liabilities$754.4k

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
ASSETS
Cash & Cash Equivalents 2.2 3.3 5.1 1.4 0.6 26 K
Short Term Investments 0 0 0 0.3 0 0
Receivables 84.7 K 32.3 K 0.1 0 69 K 83.9 K
Inventory 0 0 (0.1) 0 0 0
Other Current Assets 0.3 0.1 0.6 93.7 K 23.7 K 92.9 K
Total Current Assets 2.6 3.4 5.8 1.8 0.7 0.1
PP&E 56.6 K 0.1 0.2 0.2 0.3 0
Intangible Assets 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0
Other Long Term Assets 0 0 (0.2) (0.2) (0.3) 0
Other Assets 0 0 0 0 0 0
Total Assets 2.7 3.6 6.0 2.0 1.0 0.1
LIABILITIES
Accounts Payable 0.4 0.1 0.4 46.9 K 24.5 K 49.3 K
Short Term Debt 47.6 K 89.2 K 0.3 64.6 K 0.1 50 K
Other Current Liabilities 0.3 0.2 0.5 (0.1) 27.3 K 66.3 K
Total Current Liabilities 0.8 0.4 1.2 0.3 0.2 0.2
Long Term Debt 0 47.4 K 96.3 K 0.2 0.3 50 K
Deferred Tax Income 0 0 0 0 0 0
Other Liabilities 0 0 0 30.3 K 26 K 21.6 K
Total Liabilities 0.8 0.4 1.3 0.6 0.5 0.2
EQUITY
Common Stock 121 605 574 967 574 520
Retained Earnings (15.3) (10.3) (5.7) (3.1) (1.2) (1.2)
Other Accumulative Comprehensive Income/Loss 0 0 0 (3.1) (1.2) (1.2)
Total Equity 1.9 3.1 4.7 1.4 0.5 (0.1)
Total Liabilities and Equity 2.7 3.6 6.0 2.0 1.0 0.1
SHARES OUTSTANDING
Common Shares Outstanding 1.0 0.7 0.5 0.4 0.3 0.3